William Klitgaard

William E.
Klitgaard currently works at XiFin, Inc., as Director from 2020, Zapata Computing, Inc., as Director, ACP Charger Holdings, Inc., as Director, Zapata Quantum, Inc., as Director from 2025, and Avista Capital Holdings LP, as Operating Executive from 2020.
Mr. Klitgaard also formerly worked at BioClinica, Inc., as Director from 2018 to 2019, Liaison Technologies, Inc., as Director from 2013 to 2018, INC Research Holdings, Inc., as Independent Director, Syneos Health, Inc., as Director from 2017 to 2023, Avista Public Acquisition Corp.
II, as Independent Director, Inform Diagnostics, Inc., as Director from 2019 to 2020, Certara USA, Inc., as Director from 2017 to 2020, Zapata Quantum, Inc., as Independent Director in 2024, CNF, Inc., as Assistant Treasurer, Kenetech Corp., as Treasurer, Laboratory Corporation of America Holdings, as President-Enlighten Health from 2015 to 2016, Labcorp Drug Development, Inc., as Chief Information Officer & Senior Vice President from 2012 to 2015, and Itel Corp., as Senior Financial Analyst from 1977 to 1980.
Mr. Klitgaard received his undergraduate degree in 1975 from the University of California, Berkeley and graduate degree in 1982 from MIT Sloan School of Management.